| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at Apogee Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $121.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $56.23 | $2,249,307.04 | -1.4% | -19.4% | -29.6% | |
| Sep 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $47.62 | $1,904,841.05 | -1.4% | -1.5% | -20.9% | |
| Aug 7, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $40.62 | $1,624,764.04 | -0.9% | +42.6% | -11.9% | |
| Jul 5, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $37.26 | $558,900.00 | -1.0% | +49.5% | +3.2% | |
| Dec 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $51.52 | $515,204.08 | -1.8% | - | - | |
| Nov 16, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $45.00 | $450,000.00 | -3.6% | - | - | |
| Nov 2, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $38.36 | $383,557.65 | -1.8% | - | - | |
| Oct 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $38.83 | $388,341.83 | -1.8% | - | - | |
| Sep 18, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $40.00 | $400,000.00 | -3.6% | - | - | |
| Sep 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $28.73 | $287,334.39 | -1.8% | - | - |